Levin Zhu (L), CEO of China International Capital Corp. and son of former Chinese Premier Zhu Rongji, celebrates with Song Zhiping, chairman of Sinopharm Group, during the debut of Sinopharm Group Co. Ltd. at the Hong Kong Stock Exchange September 23, 2009. Shares of Sinopharm Group Co Ltd, China's top pharmaceutical products distributor, rose 23.4 percent in their Hong Kong debut on Wednesday, as investors bet on strong growth for China's healthcare sector. Reuters Pictures 2 months ago

Levin Zhu (L), CEO of China International Capital Corp. and son of former Chinese Premier Zhu Rongji, celebrates with Song Zhiping, chairman of Sinopharm Group, during the debut of Sinopharm Group Co. Ltd. at the Hong Kong Stock Exchange September 23, 2009. Shares of Sinopharm Group Co Ltd, China's top pharmaceutical products distributor, rose 23.4 percent in their Hong Kong debut on Wednesday, as investors bet on strong growth for China's healthcare sector.